Community News

IRVINE, Calif.--(BUSINESS WIRE)--The staff of Biogennix recently teamed with Second Harvest Food Bank to give back to the community.

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three and nine months ended September 30, 2019. Recent Corporate Highlights: Reached agreement with the U.S. Food and Drug Administration (“FDA”) […]

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the third quarter ended September 30, 2019, and provided an update on operational initiatives. Recent Business Highlights Net sales of the Axonics r-SNM® System from international […]

IRVINE, Calif.--(BUSINESS WIRE)--Freedom Innovations has announced that its Chairman, Maynard Carkhuff, has been elected President of the California Orthotic & Prosthetic Association

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration to advance its flagship GastroPlus program in support of gastrointestinal disease research

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the approval of the Axonics r-SNM® System by the United States Food & Drug Administration (“FDA”) for the clinical indications of overactive bladder (“OAB”) […]

PACIFIC PALISADES, Calif.--(BUSINESS WIRE)--Aadi Bioscience, Inc. (Aadi), a privately held clinical stage biopharmaceutical company, today released its independent radiology reviewed data from the nab-sirolimus (ABI-009) registration trial (AMPECT) for Advanced (metastatic or locally advanced) Malignant PEComa (perivascular epithelioid cell tumor) - a rare form of sarcoma for which there is no currently approved therapy. Nanoparticle albumin-bound sirolimus (nab-Sirolimus), an mTOR inhibitor, r

LOS ANGELES--(BUSINESS WIRE)--The Southern California Biomedical Council (SoCalBio) – the voice and advocate for the bioscience and digital health industries in the Greater Los Angeles region – today announced that Emmanuel Fombu, MD, MBA, Former Director of Digital Medicine and Innovation at Novartis, will deliver the keynote address at SoCalBio’s 3rd Digital Health Conference (December 13th in Santa Monica). His remarks will focus on how the Internet of Things (IoT), […]

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported results for the 4th quarter and fiscal year 2019. Full FY19 revenues increased 14.5%; 4QFY19 revenues increased 20%.

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune disease, asthma and allergic diseases, today announced that company management will participate in two upcoming conferences: Jefferies 2019 London Healthcare Conference Date: Wednesday, November 20, 2019 Presentation Time: 3:20 p.m. GMT Location: London Piper Jaffray 31st Annual Healthcare Conference Date:

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2019 Healthcare Conference at the Lotte New York Palace Hotel on Tuesday, November 19, 2019 at 10:55 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company tha

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight acquires assets and IP of MLase AG excimer ophthalmic laser system for implant-free microinvasive glaucoma surgery.

IRVINE, Calif.--(BUSINESS WIRE)---- $NVUS #earnings--Novus Therapeutics reports third quarter 2019 financial results, Phase 2a data expected in the first half 2020 & participation in investor conferences

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today an institutional placement of A$120.0 million (Institutional Placement) to fund pipeline development of new indications, including optimizing support for clinical trials and development projects, as well as the Company’s continued U.S. […]

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today reported FDA authorization of Omics Core℠, the first whole exome tumor-normal in vitro diagnostic (IVD) that measures overall tumor mutational burden (TMB) in cancer tissue. The Omics Core assay is the nation’s first FDA authorized custom-targeted whole exome sequencing platform to report both overall tumor mutation burden in tumor specimens […]

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that John Onopchenko, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, will present at the Stifel Healthcare Conference at 3:00 p.m. ET on Tuesday, November 19, 2019 in New York, NY. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at […]

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals today announced that it will host a Fiscal 2019 year end webcast and conference call on November 25, 2019, at 4:30 p.m. EST

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead and Janssen Pharmaceuticals announce clinical data on investigational hepatitis B treatments at the AASLD Liver Meeting 2019

IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden launches its new NKV-550 Series Ventilator System that offers a full suite of applications for patients of all ages.

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today that the company will be added to the S&P/ASX 200 index, effective upon market open on 14 November 2019, two months after being added to the S&P/ASX 300 index. “AVITA Medical’s inclusion in the S&P/ASX 200 index is a […]